Source link : https://newshealth.biz/health-news/first-line-immunotherapy-combo-boosts-survival-in-unresectable-liver-cancer/
(MedPage Today) — First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib (Lenvima) or sorafenib (Nexavar) for patients with unresectable hepatocellular carcinoma (HCC), the… Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/115597 Author : Publish date : 2025-05-15 15:43:00 Copyright for syndicated content belongs to the linked Source.
The post First-Line Immunotherapy Combo Boosts Survival in Unresectable Liver Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-15 15:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8